Search PubMed⌕ Search

Biomedical subjects

K Kojima

Publications and source records attributed to K Kojima.

At least 559 records · Page 31Linked to original sources
PubMed1988

[Preoperative chemoembolization of iopamiron-solved adriamycin and lipiodol on hepatocellular carcinoma--clinicopathological study of ten surgical cases].

Preoperative chemoembolization was performed in 10 patients with hepatocellular carcinoma. The therapeutic regimen included Adriamycin (ADM) solved in nonionic contrast media, Iopamiron and Lipiodol (LP). Two to four ml of the solution, containing 20-40 mg of ADM, was mixed with 5-10 ml of LP by "pumping" method. This emulsion was infused superselectively into the hepatic artery by the balloon-occluded method. The regimen contained no permanent embolic material (e.g., Gelfoam or Ivaron). Dense deposition of LP in the tumor was seen on the CT scan 3-4 weeks after TAI. Surgical specimens, resected 3-12 weeks after TAI, revealed total necrosis of the tumor in 4 cases, subtotal necrosis (more than 80% on the cut surface) in 3 cases, and partial necrosis (less than 80%) in 3 cases. Tumor invasion in the fibrous capsules was necrosed in 4/7 of the cases. Tumor thrombi in the portal vein were also necrosed in 2/4. Our new method is more effective than the previous ones of LP and ADM without Iopamiron, and is equally effective as the regimen using LP, anticancer drugs, and permanent embolic materials.

Adult↗
PubMed1988

[On the clinical usefulness of a few sugar antigens and a galactosyl-transferase].

Using human cultured cell lines or lymphocytes, two kinds of murine- and one human-monoclonal antibodies were produced, respectively and their clinical usefulness were investigated, and the possibility of galactosyl-transferase as a new tumor maker was also discussed. (1) A murine monoclonal antibody MSN-1, which was raised against human endometrial cancer cell line and recognized blood type sugar chain Leb, reacted with about 85% of endometrial cancer tissues, indicating that useful clinical information may be obtained by applying MSN-1 to immunohistochemistry and flow cytometry. (2) A new assay system using two murine monoclonal antibodies MA54 and MA61, which were raised against human lung cancer cell line and reacted with mucin sugar residues, revealed 76% positive rate in ovarian cancer patients, especially 82% in mucinous cystadenocarcinoma, indicating the clinical effectiveness as a new tumor maker compensating for the drawbacks of CA-125. (3) Galactosyl-transferase isozyme GT-2 was analyzed by the assay system using a newly produced monoclonal antibody. GT-2 was positive in 74% of ovarian cancers, especially in 89% of meso-nephroid cancer, indicating that GT-2 could be a useful tumor maker in ovarian tumors. (4) Human monoclonal antibody, which recognized "type 1 sugar chain" or iso-paragloboside, reacted about one half of endometrial cancer tissues. The production of human monoclonal antibody may contribute to the cancer imaging and the missile therapy.

Animals↗
PubMed1988

[Unruptured cerebral aneurysms in two siblings screened by cerebral computed angiotomography].

The authors report two siblings, both of whom had unruptured cerebral aneurysms found by screening examination of noninvasive cerebral computed angiotomography. Other authors have reported unruptured cerebral aneurysms detected by conventional cerebral angiography in asymptomatic relatives of families in which two or more individuals had cerebral aneurysmal rupture. It is of interest that, in our cases, the unruptured cerebral aneurysms were detected by noninvasive cerebral computed angiography in two asymptomatic siblings in a family with no history of ruptured aneurysm. To the best of our knowledge, this is the first report of detection of unruptured familial aneurysm by cerebral computed angiotomography. Case 1 is a 67-year-old female who had been complaining of dullness in the head. Cerebral computed angiotomography showed a small high density nodule, suggesting an unruptured aneurysm of the right middle cerebral artery. An aneurysm with a diameter of 4 mm was found in the right middle cerebral artery. A 72-year-old male, who was a brother of case 1, had been afraid of having cerebrovascular disease, and wanted to have a neurological examination check-up. Computed angiotomography revealed a high-density nodule in the anterior communicating artery. Conventional cerebral angiogram showed a 6 X 7 mm aneurysm. However, both of the patients refused surgical treatment. Lozano et al reviewed the previously reported familial aneurysm cases. According to them, familial aneurysm tends to rupture at a younger age and at a smaller size than non-familial aneurysm. It is well known that asymptomatic members of familial aneurysm have a risk of developing aneurysm.(ABSTRACT TRUNCATED AT 250 WORDS)

Aged↗
PubMed1988

Crossreaction of monoclonal antiidiotypic antibodies specific for human antithyroglobulin antibody with the Fc portion of human IgG.

We established 2 monoclonal antiidiotypic antibodies that reacted not only with a private idiotope on human antithyroglobulin antibody but also with the Fc portion of human IgG. These antiidiotypic antibodies (B2 and B6) bound to IgG F(ab')2 antithyroglobulin derived from a patient with chronic thyroiditis and normal human IgG, but did not bind to IgG F(ab')2 nonantithyroglobulin derived from the patient and normal human IgG F(ab')2. The antiidiotypic properties and the rheumatoid factor (RF) like properties of B2 and B6 were confirmed by inhibition assay. Our results suggest that RF may be produced as antiidiotypic antibodies specific for other antigens than IgG.

Animals↗
PubMed1987

Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase activity in vitro and tyrosine hydroxylase content.

We examined both in vitro tyrosine hydroxylase (TH) activity and TH content determined by a new enzyme immunoassay in the mouse striatum after repeated systemic injection of MPTP. Repeated systemic administration of MPTP to mice (30 mg/kg per day, subcutaneously for 8 days) caused an approximately 65% decrease of both TH activity and TH content in the striatum. The intensity of immunohistochemical staining of TH protein in the striatum was also reduced in MPTP-treated mice. These results indicate that the reduction of TH activity in vitro after the repeated administration of MPTP is due to reduction of TH protein as a result of nerve degeneration.

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine↗
PubMed1987

Heterogeneity in response to interleukin 2 and interleukin 2-producing ability of adult T cell leukemic cells.

To examine the possibility of heterogeneous mechanisms in the proliferation of adult T cell leukemia (ATL) cells, leukemic cells from 13 patients, nine acute-type and four chronic-type ATL, were examined for the production of interleukin 2 (IL 2) with or without mitogenic stimulation and their response to recombinant IL 2 when exogeneously added. The leukemic cells were classified into four groups, as follows. Group 1 (two patients): Cells of this group produced IL 2 messenger RNA, secreted IL 2, and proliferated when cultured in mitogen-free medium. The spontaneous proliferation of the cells in mitogen-free medium was inhibited by anti-Tac/IL 2 receptor and anti-IL 2 monoclonal antibodies. Moreover, the thymidine incorporation by the cells was enhanced in response to exogeneously added recombinant IL 2 and IL 2 produced by themselves. These results indicate that the ATL cells of this group proliferate with autostimulation by IL 2. Group 2 (seven patients): Cells of this group did not secrete IL 2 when cultured in mitogen-free medium, but the cells showed response to exogeneously added recombinant IL 2 and proliferated in culture. These results indicate that the ATL cells of this group proliferate by a paracrine mechanism. Group 3 (one patient): Cells of this group secreted IL 2 in mitogen-free medium. However, the spontaneous proliferation of these cells in vitro was very low, and the response to recombinant IL 2 was also very low. Group 4 (three patients): Cells of this group did not secrete IL 2 in mitogen-free medium. Spontaneous proliferation and the response to recombinant IL 2 were also very low. The clinical feature of all patients of Groups 1 and 2 was acute-type, and that of Groups 3 and 4 was chronic-type. Thus, we conclude that heterogeneous mechanisms exist in the proliferation of leukemic cells, and that growth rate in mitogen-free medium and response to IL 2 of the cells may have a significant relationship to the clinical feature, acute- or chronic-type.

Adult↗